Affymetrix, Inc. - Medical Equipment - Deals and Alliances Profile

Affymetrix, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Global Market Direct’s Affymetrix, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Affymetrix, Inc. (Affymetrix) is engaged in the business of development, production, sales and servicing of consumables and equipment systems for genetic analysis in the life sciences and clinical healthcare markets. The company’s products are widely used by pharmaceutical, biotechnology, agrichemical, diagnostics and consumer products companies as well as academic, government and other non-profit research institutes. The company offers its products under the brand names of DMET, GeneChip, NetAffx, Affymetrix, CustomSeq, GeneTitan Console. Affymetrix operations are spread across the US, Europe, Japan and several other regions. The company is headquartered in California, the US

And More inside the report…

Recent Developments

Dec 07, 2009: Affymetrix Appoints Andrew Last As New Chief Commercial Officer
Dec 07, 2009: Affymetrix Appoints Andrew Last As Chief Commercial Officer
Oct 21, 2009: Affymetrix Reports Total Revenues Of $78.2 Million In Q3 2009

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including mergers & acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick “one-stop-shop” to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Report Highlights

The following companies are the major competitors of Affymetrix, Inc.:

Agilent Technologies Inc.
Sysmex Corporation
Beckman Coulter, Inc.
Applera Corporation
Becton, Dickinson and Company
Illumina, Inc.
Invitrogen Corporation
Bayer AG
Abbott Laboratories
[Studien Infos ausblenden]

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Affymetrix, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2010 5
Affymetrix, Inc., Medical Equipment Deals By Type, 2004 to YTD 2010 6
Affymetrix, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2010 7
Affymetrix, Inc., Medical Equipment, Deals By Market, 2004 to YTD 2010 8
Affymetrix, Inc., Medical Equipment, Deals Summary, 2004 to YTD 2010 9
Affymetrix, Inc., Medical Equipment, Deal Details 10
Venture Financing 10
Panomics Secures $12.2 Million In Venture Funding 10
Molecular Profiling Raises $7.5 Million In Series B Round Of Financing 11
Perlegen Sciences Secures $74 Million In Series D Financing 12
Partnerships 14
Affymetrix Enters Into Agreement With Medical Prognosis Institute 14
Affymetrix Signs An Agreement With Asuragen 15
Affymetrix Enters Into Agreement With IPSOGEN 16
Affymetrix Enters Into Agreement With Tessarae 17
Affymetrix Enters Into Licensing Agreement With Sysmex 18
Affymetrix Enters Into Licensing Agreement With Epigenomics 19
Affymetrix Enters Into Licensing Agreement With Abbott 20
Affymetrix Enters Into Agreement With Vita Genomics 21
Affymetrix Enters Into Agreement With PathWork Diagnostics 22
Affymetrix Extends Its Agreement With bioMerieux 23
Affymetrix Enters Into Agreement With Veridex 24
Affymetrix Enters Into Co-Marketing Agreement With Sysmex 25
Debt Offering 26
Affymetrix Completes Public Offering Of $316.25 Million 26
Acquisition 27
Affymetrix Acquires Panomics 27
Affymetrix Acquires True Materials 28
Affymetrix Acquires USB 29
Affymetrix Acquires ParAllele BioScience 30
Key Competitors 31
Key Employees 31
Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 34
Strategy And Business Planning 34
Apr 15, 2008: Affymetrix Extends Collaborations In CCRP To North America 34
Financial Announcements 34
Oct 21, 2009: Affymetrix Reports Total Revenues Of $78.2 Million In Q3 2009 34
Jul 22, 2009: Affymetrix Reports Total Revenues Of $81.5 Million In Q2 2009 35
Apr 22, 2009: Affymetrix Posts Net Loss Of $25.2 Million In Q1 2009 36
Jan 28, 2009: Affymetrix Reports 2008 Results 37
Jan 28, 2009: Affymetrix reports Net Loss In Q4 2008 37
Oct 23, 2008: Affymetrix Reports 3Q 2008 Results 38
Oct 13, 2008: Affymetrix Reports Preliminary 3Q 2008 Revenue 39
Jul 24, 2008: Affymetrix Reports 2Q 2008 Results 40
Apr 24, 2008: Affymetrix Reports Q1 2008 Results 41
Apr 14, 2008: Affymetrix Declares Preliminary Q1 2008 Revenue 42
Jan 31, 2008: Affymetrix Reports Q4 2007 Results 42
Oct 24, 2007: Affymetrix Reports Q3 2007 Results 44
Jul 25, 2007: Affymetrix Reports Q2 2007 Results 45
Apr 25, 2007: Affymetrix Reports Q1 2007 Results 46
Research And Development 47
Apr 15, 2008: Affymetrix Extends Collaborations In CCRP To North America 47
Corporate Communications 47
Dec 07, 2009: Affymetrix Appoints Andrew Last As New Chief Commercial Officer 47
Dec 07, 2009: Affymetrix Appoints Andrew Last As Chief Commercial Officer 47
May 27, 2009: Affymetrix Plans To Reduce 38 Employees 48
May 11, 2009: Affymetrix Elects Gary S. Guthart To Its Board 48
Oct 22, 2008: Affymetrix Appoints New CEO 48
Oct 20, 2008: Affymetrix Appoints New Executive Vice President 49
Mar 19, 2007: Affymetrix Appoints New Board Member 49
Legal and Regulatory 49
Jun 04, 2009: Agilent Wins Patent Dispute With Affymetrix For Microarray Hybridization 49
Product News 49
Oct 14, 2009: Affymetrix Introduces Axiom Genotyping Solution 49
Appendix 51
Methodology 51
About Global Markets Direct 51
Contact Us 51
Disclaimer 51
[Inhaltsverzeichnis ausblenden]

List of Tables
Affymetrix, Inc., Medical Equipment, Key Facts, 2008 1
Panomics Secures $12.2 Million In Venture Funding 10
Molecular Profiling Raises $7.5 Million In Series B Round Of Financing 11
Perlegen Sciences Secures $74 Million In Series D Financing 12
Affymetrix Enters Into Agreement With Medical Prognosis Institute 14
Affymetrix Signs An Agreement With Asuragen 15
Affymetrix Enters Into Agreement With IPSOGEN 16
Affymetrix Enters Into Agreement With Tessarae 17
Affymetrix Enters Into Licensing Agreement With Sysmex 18
Affymetrix Enters Into Licensing Agreement With Epigenomics 19
Affymetrix Enters Into Licensing Agreement With Abbott 20
Affymetrix Enters Into Agreement With Vita Genomics 21
Affymetrix Enters Into Agreement With PathWork Diagnostics 22
Affymetrix Extends Its Agreement With bioMerieux 23
Affymetrix Enters Into Agreement With Veridex 24
Affymetrix Enters Into Co-Marketing Agreement With Sysmex 25
Affymetrix Completes Public Offering Of $316.25 Million 26
Affymetrix Acquires Panomics 27
Affymetrix Acquires True Materials 28
Affymetrix Acquires USB 29
Affymetrix Acquires ParAllele BioScience 30

List of Figures
Affymetrix, Inc., Medical Equipment, Deals By Year, 2004 to YTD 2010 5
Affymetrix, Inc., Medical Equipment, Deals by Type, 2004 to YTD 2010 6
Affymetrix, Inc., Medical Equipment, Deals By Region, 2004 to YTD 2010 7
Affymetrix, Inc., Medical Equipment, Deals by Market, 2004 to YTD 2010 8
[Tabellenverzeichnis ausblenden]